AI-generated summary
The authors randomized 27 adults with myopia to repeated low-level red-light therapy at 50 % or 100 % intensity in a crossover design and measured choroidal thickness daily. They report that both intensities produced similar significant choroidal thickening after one month, which they suggest could indicate comparable myopia control efficacy with less energy use. Choroidal thickness was used as a surrogate outcome, so clinical myopia control was not directly measured.
- Participants
- 27
- Who or what was studied
- Adults aged 18-40 years with myopia (mean age 21.2 years)
- Limits stated in the abstract
- Choroidal thickness is a surrogate outcome rather than a direct measure of myopia progression, and the sample size is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Myopia, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.